Continuous Glucose Monitoring Effects on Maternal Glycemic Control and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Prospective Cohort Study
Initiatives
-
The objective was to evaluate the effectiveness of CGM on maternal glycemic control and pregnancy outcomes in patients with GDM .
Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
- Start Year
- 2011
- Funding
- This work was supported by a grant from Guangdong Science and Technology Department, China (2011B31800264). J.N. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Design
- Study design
- Patients' cohort
Marker Paper
Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(12):4674‐4682. doi:10.1210/jc.2013-4332
PUBMED 25057872
Number of participants
- Number of participants
- 340
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |
Timeline
pregnant women with GDM
The present study, conducted by the Department of Obstetrics of GuangDong Women and Children Hospital in Guangzhou, China, enrolled a total of 340 pregnant Han Chinese women with GDM at 24 to 28 gestational weeks of a singleton pregnancy. Patient demographics included age, parity, childbearing history, past medical history, prepregnancy body weight, height, blood pressure, and fasting glucose concentrations in the first trimester.
Selection Criteria
- Gender
-
women
- Pregnant women
-
- Second Trimester
- Third Trimester
- Newborns
- Twins
- Countries
-
- China
- Ethnic Origin
-
- Health Status
-
- The exclusion criteria included a diagnosis of diabetes before knowledge of pregnancy, a fasting glucose level of more than 5.1 mmol/L in the first trimester.
- Other criteria
- Reluctance to be examined regularly in the Department of Obstetrics of GuangDong Women and Children Hospital, delivery of the infant in another hospital, multiple pregnancies, and a diagnosis of overt diabetes during the current pregnancy or complicated pregnancies as a consequence of other medical diseases.
Recruitment
- Sources of recruitment
-
- Specific population
Number of participants
- Number of participants
- 340
- Number of participants with biosamples
Data Collection Event
All patients were taught to self-monitor their blood glucose levels 7 times a day with the Abbott Optium Xceed glucometer and the self-code data submitted into the patient's private meter.
- Start Date
-
2011-04
- End Date
-
2012-08
- Data sources
-
-
Mobile data collection
- Abbott Optium Xceed glucometer
-
Mobile data collection